Abstract

The natural killer group 2 members D (NKG2D) is an activating receptor which plays a major role in immune surveillance, and the detection and elimination of malignant tumors and infected cells. NKG2D acts over both arms of the vertebrate immune response, and is expressed in some human and mouse myelopoietic, γδ T, NKT and CD4+ cells, but is present in all NK and CD8+ T cells in humans and activated mouse CD8+ T cells. In humans, eight ligands which selectively bind to the NKG2D receptor have been identified. These ligands are not systemically expressed, but are triggered in response to stress and expressed only under specific pathological states. Several research results point to the importance of cytokines for increasing expression of NKG2D to restore the functionality of NK cells as well as their ligands in the target cells. However, the NKG2D system itself in an activated state, also release pro and anti-inflammatory cytokine transcripts to establish communication with other cells or for self-regulation. Additionally, type I antiviral interferon is largely produced. Such cytokine interactions could be regarded as a double edged sword. This behavior is emphasized by a discrepancy regarding the functionality of cytokines which interact with, or on the NKG2D system. Indeed, they seem to protect the host and rather can induce ligand expression, cell proliferation or dissemination of malignant tumors, generating complicated cytokine-mediated messenger loops which are far from being fully understood. Whatever the case, cytokines related to the NKG2D system could be an attractive and useful target for immunotherapeutic approaches. Thus, here we briefly review recent findings on the main aspects involved in the regulation of this system and, particularly, attempt to clarify the role played by cytokines in the activating or inhibitory function they exert over the NKG2D system in different contexts.

Highlights

  • Cells communicate with one another through extracellular signalling proteins know as cytokines

  • Song and colleagues [89] demonstrated that the combination of IL-2 with IL-18 can protect the TGF-β1-induced natural killer group 2 members D (NKG2D) down-modulation in natural killer (NK) cells via the JNK pathway

  • It is clear that the stimulation of CD8+ cells with cytokines results in antigen-nonspecific expansion, which is useful for immunotherapy in the treatment of advanced tumor models and represents a primary effector mechanism [131]

Read more

Summary

Introduction

Cells communicate with one another through extracellular signalling proteins know as cytokines. The MICA, MICB and the ULBPs, known as retinoic acid early transcript RAET1 proteins, have been seen to be upregulated in cancer and infected cells [8,78,81,98] These ligands are recognized by the immune activating receptor NKG2D. Cytokine stimulation of cells may overcome receptor inhibition mediated by soluble ligands To illustrate this mechanism, Song and colleagues [89] demonstrated that the combination of IL-2 with IL-18 can protect the TGF-β1-induced NKG2D down-modulation in NK cells via the JNK pathway.

A Key Player in Immunotherapy: the Cytokines
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call